Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00624234 · ClinicalTrials.gov registry record · NA
Neurobiology and Treatment of Reading Disability in NF-1
A NA study, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 184
- Enrollment target
NCT00624234 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 184 participants.
The verdict
NCT00624234, a NA study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 184 participants
- Enrollment target
Study Summary
The goal of this trial is to determine if children with neurofibromatosis type 1 who have reading disabilities respond the same way-both behaviorally and neurobiologically-to specialized treatment programs as children with idiopathic reading disabilities do, and to determine which intervention is best for particular learner profiles.
Interventions
- BEHAVIORAL Tutoring Program I
- BEHAVIORAL Tutoring Program II
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 184 participants |
| Start Date | 2006-02 |
| Est. Completion | 2017-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00624234
The ClinicalTrials.gov registry entry for NCT00624234 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 184 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tutoring Program I is the first listed.
NCT00624234 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00624234 about?
NCT00624234 is a clinical study titled "Neurobiology and Treatment of Reading Disability in NF-1". The goal of this trial is to determine if children with neurofibromatosis type 1 who have reading disabilities respond the same way-both behaviorally and neurobiologically-to specialized treatment programs as children with idiopathic reading disabilities do, and to determine which intervention is be...
What is the current status of trial NCT00624234?
This trial is currently completed. It is a NA study. The enrollment target is 184 participants. The study started on 2006-02. Estimated completion is 2017-01.
What interventions are being tested in trial NCT00624234?
The interventions under investigation include: Tutoring Program I (BEHAVIORAL), Tutoring Program II (BEHAVIORAL).
Who is sponsoring clinical trial NCT00624234?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.